Побочки от плацебо
Jan. 20th, 2022 10:08 am![[personal profile]](https://www.dreamwidth.org/img/silk/identity/user.png){kind=small}
ny_quantQuestion What was the frequency of adverse events (AEs) in the placebo groups of COVID-19 vaccine trials?
Findings In this systematic review and meta-analysis of 12 articles including AE reports for 45 380 trial participants, systemic AEs were experienced by 35% of placebo recipients after the first dose and 32% after the second. Significantly more AEs were reported in the vaccine groups, but AEs in placebo arms (“nocebo responses”) accounted for 76% of systemic AEs after the first COVID-19 vaccine dose and 52% after the second dose.
Здесь объясняют популярно, для невежд
Findings In this systematic review and meta-analysis of 12 articles including AE reports for 45 380 trial participants, systemic AEs were experienced by 35% of placebo recipients after the first dose and 32% after the second. Significantly more AEs were reported in the vaccine groups, but AEs in placebo arms (“nocebo responses”) accounted for 76% of systemic AEs after the first COVID-19 vaccine dose and 52% after the second dose.
Здесь объясняют популярно, для невежд
